It has been shown that AGHD, similar to metabolic syndrome, is strongly associated with a chronic inflammatory state and that serum levels of lipocalin-2 (LCN2) are significantly elevated in patients with AGHD compared to the healthy population (4). Here, LCN2 is linked to metabolic syndrome.